Antibiotics Market Overview, Business Opportunities future, growth 2027 - PowerPoint PPT Presentation

About This Presentation
Title:

Antibiotics Market Overview, Business Opportunities future, growth 2027

Description:

The antibiotics market was valued at US$ 44,111.31 million in 2020 and is projected to reach US$ 59,253.24 million in 2028; it is expected to grow at a CAGR of 4.0% during 2021–2028. – PowerPoint PPT presentation

Number of Views:3
Slides: 9
Provided by: Marketnews89

less

Transcript and Presenter's Notes

Title: Antibiotics Market Overview, Business Opportunities future, growth 2027


1
Antibiotics Market Overview, Business
Opportunities future, growth 2027
  • Published Date May 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com
  • Antibiotics Market Forecast to 2028 - COVID-19
    Impact and Global Analysis By Drug Class
    (Sulfonamides, Aminoglycosides, Carbapenem,
    Macrolides, Fluoroquinolones, Penicillin,
    Cephalosporin, Others) Action Mechanism (Mycolic
    Acid Inhibitors, RNA Synthesis Inhibitors, DNA
    Synthesis Inhibitors, Protein Synthesis
    Inhibitors, Cell Wall Synthesis Inhibitors), and
    Geography

3
Antibiotics Market Overview
Email sales_at_theinsightpartners.com
  • The Antibiotics Market was valued at US
    44,111.31 million in 2020 and is projected to
    reach US 59,253.24 million in 2028 it is
    expected to grow at a CAGR of 4.0 during
    20212028.
  • Based on n drug class, the antibiotics market is
    segmented into Cephalosporin, Penicillin,
    Fluoroquinolones, Macrolides, Carbapenem,
    Aminoglycosides, Sulfonamides, and Others. The
    cephalosporin segment held the largest share of
    the market in 2020 however the fluoroquinolones
    segment is anticipated to register the highest
    CAGR of 5.3 in the market during the forecast
    period. Additionally, increasing incidence of
    pneumonia, bloodstream infections, and Urinary
    Tract Infections (UTI) is expected to increase
    the demand for carbapenems class of antibiotics
    in coming years. Moreover, the lower price of
    generic carbapenem-based antibiotics is expected
    to result in increased product adoption, thus
    compelling carbapenem-based antibiotic
    manufacturers to develop geographical footprint
    in lower and middle-income countries.

4
Key Segment Market
Email sales_at_theinsightpartners.com
  • Segment By Type-
  • By Drug Class (Cephalosporin, Penicillin,
    Fluoroquinolones, Macrolides, Carbapenem,
  • Aminoglycosides, Sulfonamides, Others)
  • By Action Mechanism (Cell Wall Synthesis
    Inhibitors, Protein Synthesis Inhibitors, Dna
    Synthesis Inhibitors, Rna Synthesis Inhibitors,
    Mycolic Acid Inhibitors, Others)

Download Sample
5
Antibiotics Market Value
Email sales_at_theinsightpartners.com
  • CAGR of 4.0
  • (2021 - 2028)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com
  • Pfizer, Inc
  • Johnson Johnson Services, Inc. (Janssen
    Pharmaceuticals),
  • Abbott,
  • GlaxoSmithKline Plc,
  • Sanofi,
  • Novartis AG,
  • Bayer AG,
  • Bristol Myers Squibb Company,
  • Eli Lilly and Company,
  • Astellas Pharma

Download Sample
7
By Geography
Email sales_at_theinsightpartners.com
  • North America (the US, Canada, and Mexico)
  • Europe (the UK, Germany, France, Italy, Spain,
    and the Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia,
    South Korea, and the Rest of Asia Pacific)
  • Middle East Africa (the UAE, Saudi Arabia,
    South Africa, and the Rest of Middle East
    Africa)
  • South Central America (Brazil, Argentina, and
    the Rest of South Central America).

8
THANKYOU!
  • Phone  1-646-491-9876
  • E-Mail sales_at_theinsightpartners.com
Write a Comment
User Comments (0)
About PowerShow.com